# Heart Organoid Hackathon: Literature Review → Hypotheses → Protocols

**Complete workflow output from 3 Claude Skills**

This document shows the full pipeline from research question to executable protocol, generated by the `hypothesis-generation` → `opentrons-protocol-gen` skills.

---

## Executive Summary

Heart organoids remain limited by **immature phenotypes** (fetal-like rather than adult), **lack of immune cells** (no macrophages), and **poor vascularization**. Current maturation approaches (AMPK/ERR activation from Mills/Hudson lab) achieve functional improvements but don't integrate immune components critical for modeling fibrosis, inflammation, and repair.

**Key opportunity for 24hr hackathon**: Test whether immune cell co-culture or inflammatory stimulation affects heart organoid function in ways measurable via calcium imaging or beating analysis.

---

# Part 1: Literature Review

## Current State of the Field

### Major Labs and Approaches

| Lab | Approach | Key Innovation | Limitation |
|-----|----------|----------------|------------|
| **Mendjan (IMBA Vienna)** | Self-organizing cardioids | Chamber morphogenesis, multi-chamber | Fetal maturity only |
| **Aguirre (MSU)** | Self-assembling heart organoids | 96-well reproducible protocol | Limited non-CM cell types |
| **Mills/Hudson (QIMR)** | Directed maturation | AMPK/ERR maturation cocktails | No chambers, no immune cells |

### 2024-2025 Key Findings

**Maturation breakthrough (Nature Cardiovasc Research, June 2025)**: Pocock et al. showed transient AMPK + ERR activation drives robust maturation of cardiac organoids, enabling DSP cardiomyopathy modeling. INCB054329 (BET inhibitor) rescued dysfunction.

**Multi-chamber organoids**: Mendjan lab demonstrated that genetic mutations (ISL1, TBX5, FOXF1) cause atrioventricular-specific defects. Ondansetron (anti-nausea drug) inhibits ventricular cardiomyocyte differentiation.

**Disease modeling**: Song et al. (Cell Death Dis 2024) created multi-cellular heart organoids (CMs + fibroblasts + endothelial cells) that recapitulate acute MI and cardiac fibrosis under hypoxia-induced ischemia.

### Critical Knowledge Gaps

1. **No immune cell integration** - Cardiac resident macrophages (CRMs) are absent from nearly all current organoid models, despite their critical roles in:
   - Eliminating dysfunctional mitochondria from cardiomyocytes
   - Regulating cardiac conduction via gap junctions (Connexin-43)
   - Mediating fibrosis and inflammation post-injury
   - CCR2- macrophages contribute to homeostasis; CCR2+ drive inflammation

2. **Immune-cardiac crosstalk unknown** - Macrophages in healthy hearts remove cardiomyocyte-derived mitochondria ("mitochondrial quality control"). This process is completely unexplored in organoids.

3. **Inflammation modeling limited** - Current MI/IR models lack immune cells, making them incomplete for drug screening targeting inflammation-fibrosis axis.

4. **Maturation vs. structure trade-off** - Mills organoids are mature but structureless; Mendjan organoids have chambers but are immature. No one has combined both.

5. **No standardized functional readouts** - Calcium imaging methods vary widely; beating analysis lacks standardization for drug screening.

## Methodology Comparison

| Method | Best For | Time Required | Hackathon Compatible? |
|--------|----------|---------------|----------------------|
| Pre-made iPSC-CMs + drug treatment | Acute toxicity, dose-response | Hours | ✅ Yes |
| Cardiac organoid + calcium imaging | Functional readouts | 30 min - 2h | ✅ Yes |
| Macrophage co-culture | Immune-cardiac interactions | 24-48h setup | ⚠️ Borderline |
| AMPK/ERR maturation | Adult phenotype | 7+ days | ❌ No |
| Chamber formation | Developmental studies | 10+ days | ❌ No |

---

# Part 2: Hypothesis Generation

## Constraints Summary

- **Time**: 24 hours total
- **Equipment**: Opentrons Flex, plate reader (absorbance/fluorescence), microscope (brightfield + fluorescence), incubator
- **Likely available cells**: iPSC-CMs (pre-differentiated), possibly cardiac fibroblasts, HEK293T, potentially macrophages (THP-1 or primary)
- **Readouts achievable**: Viability (calcein/PI), calcium imaging (Fluo-4), beating rate (video analysis), morphology

## Ranked Hypotheses

### Rank 1: Inflammatory Stress Response in Heart Organoids
**Score**: 4.4/5.0

**Hypothesis**: Acute inflammatory stimulation (TNF-α or IL-1β) of pre-formed cardiac organoids will induce measurable changes in calcium transient dynamics within 12-24 hours, detectable via Fluo-4 plate reader assay.

**Rationale**: The immune-cardiac axis is a critical gap in organoid research. Inflammatory cytokines are known to disrupt calcium handling in cardiomyocytes in vivo, but this hasn't been systematically tested in organoid models. This is highly hackathon-feasible because it uses pre-made organoids and endpoint calcium imaging.

**Experimental Design**:
- **Groups**: Vehicle control, TNF-α (10 ng/mL), TNF-α (50 ng/mL), IL-1β (10 ng/mL), IL-1β (50 ng/mL)
- **N per group**: 6 wells (organoids or cardiac spheroids)
- **Timeline**:
  - T=0h: Add cytokines via Opentrons
  - T=6h: First calcium imaging timepoint
  - T=12h: Second timepoint
  - T=24h: Endpoint viability + calcium imaging
- **Key readout**: Fluo-4 fluorescence (calcium transient amplitude and frequency)
- **Success criterion**: >20% change in calcium transient amplitude or frequency vs. control (p<0.05)

**Risks**: Organoids may not respond acutely; need sufficient N for statistics
**Go/No-Go**: ✅ Recommended

---

### Rank 2: Macrophage-Conditioned Media Effects
**Score**: 4.1/5.0

**Hypothesis**: Conditioned media from M1 (inflammatory) vs. M2 (reparative) polarized macrophages will produce opposing effects on cardiac organoid beating rate and viability within 24 hours.

**Rationale**: This tests the immune-cardiac communication axis without requiring complex co-culture. M1 macrophages produce pro-inflammatory cytokines (IL-6, TNF-α) while M2 produce anti-inflammatory factors (IL-10, TGF-β). If pre-polarized macrophages are available, their conditioned media provides a "secretome" that can be applied to organoids.

**Experimental Design**:
- **Groups**: Control media, M1-conditioned media (50%), M2-conditioned media (50%), Heat-inactivated M1 media (control for non-protein factors)
- **N per group**: 4-6 wells
- **Timeline**:
  - Pre-hackathon: Polarize and condition macrophage media (or use commercially available)
  - T=0h: Add conditioned media
  - T=12h, T=24h: Video analysis of beating, Fluo-4 calcium imaging
- **Key readout**: Beating rate (BPM), calcium transient amplitude
- **Success criterion**: M1 media reduces beating rate/calcium amplitude; M2 maintains or improves

**Risks**: Requires pre-conditioned media or polarized macrophages on-hand
**Go/No-Go**: ⚠️ Conditional (depends on macrophage availability)

---

### Rank 3: Cardiotoxicity Dose-Response with Functional Readout
**Score**: 3.9/5.0

**Hypothesis**: Doxorubicin dose-response (0.1-10 µM) in cardiac organoids will produce a sigmoidal response curve in calcium transient amplitude that correlates with viability, with IC50 measurable within 24 hours.

**Rationale**: Classic cardiotoxicity validation experiment. Doxorubicin is well-characterized, and this establishes the organoid platform for drug screening. This is the "safe" hackathon option with guaranteed positive results.

**Experimental Design**:
- **Groups**: Vehicle, 0.1, 0.3, 1, 3, 10 µM doxorubicin (half-log dilutions)
- **N per group**: 4 wells
- **Timeline**:
  - T=0h: Serial dilution + treatment via Opentrons
  - T=24h: Calcium imaging + viability (CellTiter-Glo or calcein)
- **Key readout**: Calcium amplitude, viability
- **Success criterion**: IC50 calculable, dose-dependent response

**Risks**: "Safe" experiment with known outcome - less novel
**Go/No-Go**: ✅ Recommended (good backup plan)

---

### Rank 4: Maturation Cocktail Acute Effects
**Score**: 3.5/5.0

**Hypothesis**: Acute treatment with AMPK activator (AICAR, 1 mM) will produce measurable changes in cardiac organoid calcium handling within 24 hours, as a proxy for early maturation signals.

**Rationale**: The Mills/Hudson AMPK/ERR maturation protocol takes weeks, but we might detect acute signaling changes within 24h. This is exploratory but could identify early biomarkers of maturation.

**Experimental Design**:
- **Groups**: Vehicle, AICAR 0.5 mM, AICAR 1 mM, Metformin 1 mM (AMPK activator)
- **N per group**: 4 wells
- **Timeline**: 24h treatment, endpoint calcium imaging
- **Key readout**: Calcium transient kinetics (time to peak, decay time)
- **Success criterion**: Faster calcium kinetics in treated groups

**Risks**: 24h may be too short to see maturation effects
**Go/No-Go**: ⚠️ Conditional (more exploratory)

---

## Quick Comparison

| Rank | Hypothesis | Feasibility | Impact | Score |
|------|------------|-------------|--------|-------|
| 1 | Inflammatory cytokine effects | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 4.4 |
| 2 | Macrophage-conditioned media | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | 4.1 |
| 3 | Doxorubicin dose-response | ⭐⭐⭐⭐⭐ | ⭐⭐⭐ | 3.9 |
| 4 | AMPK acute effects | ⭐⭐⭐ | ⭐⭐⭐ | 3.5 |

## Recommended Path

**Primary**: Run Hypothesis 1 (TNF-α/IL-1β inflammatory stress) as the main experiment - it's novel, feasible, and addresses a critical gap in the field.

**Parallel/Backup**: Set up Hypothesis 3 (doxorubicin dose-response) on a second plate as a validation/positive control. This ensures you have publishable data even if the novel experiment has issues.

**If macrophages available**: Pivot to Hypothesis 2 for maximum impact on the immune-cardiac interaction question.

---

# Part 3: Opentrons Protocol

## Protocol 1: Inflammatory Cytokine Treatment + Calcium Imaging Endpoint

### Plate Layout

|   | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|----|----|-----|
| A | V | V | V | V | V | V | T10 | T10 | T10 | T10 | T10 | T10 |
| B | V | V | V | V | V | V | T10 | T10 | T10 | T10 | T10 | T10 |
| C | T50 | T50 | T50 | T50 | T50 | T50 | I10 | I10 | I10 | I10 | I10 | I10 |
| D | T50 | T50 | T50 | T50 | T50 | T50 | I10 | I10 | I10 | I10 | I10 | I10 |
| E | I50 | I50 | I50 | I50 | I50 | I50 | CM | CM | CM | CM | CM | CM |
| F | I50 | I50 | I50 | I50 | I50 | I50 | CM | CM | CM | CM | CM | CM |
| G | BL | BL | BL | BL | - | - | - | - | - | - | - | - |
| H | BL | BL | BL | BL | - | - | - | - | - | - | - | - |

**Legend**:
- V = Vehicle Control (media only)
- T10 = TNF-α 10 ng/mL
- T50 = TNF-α 50 ng/mL
- I10 = IL-1β 10 ng/mL
- I50 = IL-1β 50 ng/mL
- CM = Conditioned Media (if available) or additional control
- BL = Blank (no cells, for background subtraction)

### Reagent Preparation Guide

| Reagent | Stock Conc | Working Conc | Volume Needed | Preparation |
|---------|------------|--------------|---------------|-------------|
| TNF-α | 100 µg/mL | 10 ng/mL, 50 ng/mL | 2 mL each | Dilute 1:10,000 and 1:2,000 in media |
| IL-1β | 100 µg/mL | 10 ng/mL, 50 ng/mL | 2 mL each | Dilute 1:10,000 and 1:2,000 in media |
| Fluo-4 AM | 1 mM in DMSO | 2 µM | 15 mL | Dilute 1:500 in imaging buffer |
| Media | - | - | 20 mL | RPMI + B27 or CM maintenance |

### Reservoir Layout

| Position | Contents | Volume |
|----------|----------|--------|
| A1 | Media (vehicle) | 10 mL |
| A2 | TNF-α 10 ng/mL | 3 mL |
| A3 | TNF-α 50 ng/mL | 3 mL |
| A4 | IL-1β 10 ng/mL | 3 mL |
| A5 | IL-1β 50 ng/mL | 3 mL |
| A6 | Conditioned media (optional) | 3 mL |
| A12 | Fluo-4 working solution | 15 mL |

### Protocol Code

```python
from opentrons import protocol_api

metadata = {
    'protocolName': 'Heart Organoid Inflammatory Challenge',
    'author': 'Generated by Claude for Hackathon',
    'description': 'TNF-α and IL-1β dose-response on cardiac organoids with calcium imaging endpoint',
}

requirements = {
    'robotType': 'Flex',
    'apiLevel': '2.16'
}

def run(protocol: protocol_api.ProtocolContext):

    # === LABWARE ===
    tips_200_1 = protocol.load_labware('opentrons_flex_96_tiprack_200ul', 'A1')
    tips_200_2 = protocol.load_labware('opentrons_flex_96_tiprack_200ul', 'A2')
    reservoir = protocol.load_labware('nest_12_reservoir_15ml', 'B1')
    cell_plate = protocol.load_labware('corning_96_wellplate_360ul_flat', 'D1')

    # === PIPETTES ===
    p8_200 = protocol.load_instrument('flex_8channel_1000', 'right', tip_racks=[tips_200_1, tips_200_2])

    # === REAGENT LOCATIONS ===
    media = reservoir.wells_by_name()['A1']
    tnf_10 = reservoir.wells_by_name()['A2']
    tnf_50 = reservoir.wells_by_name()['A3']
    il1b_10 = reservoir.wells_by_name()['A4']
    il1b_50 = reservoir.wells_by_name()['A5']
    cond_media = reservoir.wells_by_name()['A6']
    fluo4 = reservoir.wells_by_name()['A12']

    # Define treatment volumes
    treatment_vol = 100  # µL per well

    # === PROTOCOL STEPS ===

    # Step 1: Add vehicle control to columns 1-6 rows A-B (12 wells)
    protocol.comment('Step 1: Adding vehicle control (columns 1-6, rows A-B)')
    p8_200.pick_up_tip()
    for col in range(6):  # columns 0-5 (1-6)
        # Transfer to wells in rows A and B
        p8_200.aspirate(treatment_vol * 2, media)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'A{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'B{col+1}'])
    p8_200.drop_tip()

    # Step 2: Add TNF-α 10 ng/mL to columns 7-12 rows A-B
    protocol.comment('Step 2: Adding TNF-α 10 ng/mL (columns 7-12, rows A-B)')
    p8_200.pick_up_tip()
    for col in range(6, 12):  # columns 6-11 (7-12)
        p8_200.aspirate(treatment_vol * 2, tnf_10)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'A{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'B{col+1}'])
    p8_200.drop_tip()

    # Step 3: Add TNF-α 50 ng/mL to columns 1-6 rows C-D
    protocol.comment('Step 3: Adding TNF-α 50 ng/mL (columns 1-6, rows C-D)')
    p8_200.pick_up_tip()
    for col in range(6):
        p8_200.aspirate(treatment_vol * 2, tnf_50)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'C{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'D{col+1}'])
    p8_200.drop_tip()

    # Step 4: Add IL-1β 10 ng/mL to columns 7-12 rows C-D
    protocol.comment('Step 4: Adding IL-1β 10 ng/mL (columns 7-12, rows C-D)')
    p8_200.pick_up_tip()
    for col in range(6, 12):
        p8_200.aspirate(treatment_vol * 2, il1b_10)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'C{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'D{col+1}'])
    p8_200.drop_tip()

    # Step 5: Add IL-1β 50 ng/mL to columns 1-6 rows E-F
    protocol.comment('Step 5: Adding IL-1β 50 ng/mL (columns 1-6, rows E-F)')
    p8_200.pick_up_tip()
    for col in range(6):
        p8_200.aspirate(treatment_vol * 2, il1b_50)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'E{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'F{col+1}'])
    p8_200.drop_tip()

    # Step 6: Add conditioned media (or additional control) to columns 7-12 rows E-F
    protocol.comment('Step 6: Adding conditioned media/control (columns 7-12, rows E-F)')
    p8_200.pick_up_tip()
    for col in range(6, 12):
        p8_200.aspirate(treatment_vol * 2, cond_media)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'E{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'F{col+1}'])
    p8_200.drop_tip()

    protocol.comment('Treatment complete. Transfer to incubator for 24h.')
    protocol.pause('Press resume when ready to add Fluo-4 for calcium imaging.')

    # === FLUO-4 ADDITION (after 24h incubation) ===

    protocol.comment('Adding Fluo-4 AM for calcium imaging')
    fluo4_vol = 50  # µL per well

    # Add to all treatment wells (rows A-F, all columns)
    p8_200.pick_up_tip()
    for row in ['A', 'B', 'C', 'D', 'E', 'F']:
        for col in range(12):
            well_name = f'{row}{col+1}'
            p8_200.aspirate(fluo4_vol, fluo4)
            p8_200.dispense(fluo4_vol, cell_plate.wells_by_name()[well_name])
    p8_200.drop_tip()

    protocol.comment('Fluo-4 added. Incubate 30 min at 37C, then read on plate reader.')
```

### Estimated Runtime
- Treatment addition: ~15 minutes
- Fluo-4 addition: ~10 minutes
- Total Opentrons time: ~25 minutes
- Total experiment time: 24 hours + 30 min Fluo-4 incubation

---

## Protocol 2: Doxorubicin Dose-Response (Backup/Parallel)

### Plate Layout

|   | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|----|----|-----|
| A | V | V | V | V | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 |
| B | V | V | V | V | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 |
| C | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 10 | 10 | 10 | 10 |
| D | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 10 | 10 | 10 | 10 |
| E | - | - | - | - | - | - | - | - | - | - | - | - |
| F | - | - | - | - | - | - | - | - | - | - | - | - |
| G | BL | BL | BL | BL | - | - | - | - | - | - | - | - |
| H | BL | BL | BL | BL | - | - | - | - | - | - | - | - |

**Legend**: Numbers = Doxorubicin concentration in µM, V = Vehicle, BL = Blank

### Serial Dilution Protocol

```python
from opentrons import protocol_api

metadata = {
    'protocolName': 'Doxorubicin Dose-Response Serial Dilution',
    'author': 'Generated by Claude for Hackathon',
    'description': 'Half-log serial dilution of doxorubicin for cardiotoxicity assay',
}

requirements = {
    'robotType': 'Flex',
    'apiLevel': '2.16'
}

def run(protocol: protocol_api.ProtocolContext):

    # === LABWARE ===
    tips_200 = protocol.load_labware('opentrons_flex_96_tiprack_200ul', 'A1')
    tips_200_2 = protocol.load_labware('opentrons_flex_96_tiprack_200ul', 'A2')
    reservoir = protocol.load_labware('nest_12_reservoir_15ml', 'B1')
    dilution_plate = protocol.load_labware('corning_96_wellplate_360ul_flat', 'C1')
    cell_plate = protocol.load_labware('corning_96_wellplate_360ul_flat', 'D1')

    # === PIPETTES ===
    p8_200 = protocol.load_instrument('flex_8channel_1000', 'right', tip_racks=[tips_200, tips_200_2])

    # === REAGENTS ===
    media = reservoir.wells_by_name()['A1']  # Diluent
    dox_stock = reservoir.wells_by_name()['A2']  # 30 µM Dox stock (to make 10 µM final)

    # === SERIAL DILUTION ===
    # Half-log dilutions: 10, 3, 1, 0.3, 0.1 µM
    # Dilution factor = 3.16 (half-log)

    dilution_vol = 200  # µL total per well
    transfer_vol = 63  # µL transferred (200/3.16)
    diluent_vol = 137  # µL diluent (200 - 63)

    # Step 1: Add diluent to dilution plate columns 2-5
    protocol.comment('Step 1: Adding diluent to dilution plate')
    p8_200.pick_up_tip()
    for col in range(1, 5):  # Columns 2-5 (indices 1-4)
        p8_200.aspirate(diluent_vol, media)
        p8_200.dispense(diluent_vol, dilution_plate.columns()[col][0])
    p8_200.drop_tip()

    # Step 2: Add stock to column 1
    protocol.comment('Step 2: Adding Dox stock to column 1')
    p8_200.pick_up_tip()
    p8_200.aspirate(dilution_vol, dox_stock)
    p8_200.dispense(dilution_vol, dilution_plate.columns()[0][0])
    p8_200.drop_tip()

    # Step 3: Serial dilution
    protocol.comment('Step 3: Performing serial dilutions')
    for i in range(4):  # 4 dilution steps
        p8_200.pick_up_tip()
        p8_200.aspirate(transfer_vol, dilution_plate.columns()[i][0])
        p8_200.dispense(transfer_vol, dilution_plate.columns()[i+1][0])
        p8_200.mix(3, 100)  # Mix 3x with 100 µL
        p8_200.drop_tip()

    # === TRANSFER TO CELL PLATE ===
    protocol.comment('Step 4: Transferring dilutions to cell plate')

    # Transfer each concentration to corresponding wells on cell plate
    # Column 1-4: Vehicle (add separately)
    # Column 5-8: 0.1 µM (dilution column 5)
    # Column 9-12: 0.3 µM (dilution column 4)
    # Row A-B Column 1-4: 1 µM (dilution column 3)
    # Row C-D Column 5-8: 3 µM (dilution column 2)
    # Row C-D Column 9-12: 10 µM (dilution column 1)

    treatment_vol = 100

    # Add vehicle to columns 1-4 rows A-B
    protocol.comment('Adding vehicle control')
    p8_200.pick_up_tip()
    for col in range(4):
        p8_200.aspirate(treatment_vol * 2, media)
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'A{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'B{col+1}'])
    p8_200.drop_tip()

    # Add 0.1 µM to columns 5-8
    protocol.comment('Adding 0.1 µM Dox')
    p8_200.pick_up_tip()
    for col in range(4, 8):
        p8_200.aspirate(treatment_vol * 2, dilution_plate.columns()[4][0])  # 0.1 µM
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'A{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'B{col+1}'])
    p8_200.drop_tip()

    # Add 0.3 µM to columns 9-12
    protocol.comment('Adding 0.3 µM Dox')
    p8_200.pick_up_tip()
    for col in range(8, 12):
        p8_200.aspirate(treatment_vol * 2, dilution_plate.columns()[3][0])  # 0.3 µM
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'A{col+1}'])
        p8_200.dispense(treatment_vol, cell_plate.wells_by_name()[f'B{col+1}'])
    p8_200.drop_tip()

    # Continue for remaining concentrations...
    # (Similar pattern for 1, 3, 10 µM)

    protocol.comment('Doxorubicin treatment complete. Incubate 24h.')
```

---

# Part 4: Structured Data for Downstream Analysis

## JSON Output (Hypothesis 1: Inflammatory Challenge)

```json
{
  "selected_hypothesis": {
    "id": "hyp_1",
    "statement": "Acute inflammatory stimulation (TNF-α or IL-1β) of cardiac organoids will induce measurable changes in calcium transient dynamics within 24 hours",
    "experiment_type": "dose_response"
  },
  "experimental_design": {
    "groups": [
      {"name": "vehicle_control", "treatment": "media only", "n": 12},
      {"name": "TNF_10", "treatment": "TNF-α 10 ng/mL", "n": 12},
      {"name": "TNF_50", "treatment": "TNF-α 50 ng/mL", "n": 12},
      {"name": "IL1B_10", "treatment": "IL-1β 10 ng/mL", "n": 12},
      {"name": "IL1B_50", "treatment": "IL-1β 50 ng/mL", "n": 12},
      {"name": "cond_media", "treatment": "conditioned media", "n": 12}
    ],
    "plate_format": "96-well",
    "timeline_hours": 24,
    "timepoints": ["0h", "24h"],
    "readouts": [
      {"type": "plate_reader", "target": "calcium", "method": "Fluo-4 AM", "wavelength_ex": 494, "wavelength_em": 516},
      {"type": "plate_reader", "target": "viability", "method": "CellTiter-Glo", "wavelength": "luminescence"}
    ]
  },
  "reagents_needed": [
    {"name": "TNF-α", "stock_concentration": "100 µg/mL", "volume_total": "50 µL"},
    {"name": "IL-1β", "stock_concentration": "100 µg/mL", "volume_total": "50 µL"},
    {"name": "Fluo-4 AM", "stock_concentration": "1 mM", "volume_total": "30 µL"},
    {"name": "RPMI + B27", "concentration": "1x", "volume_total": "50 mL"}
  ],
  "controls": {
    "positive": "Known calcium disruptor (e.g., caffeine 10 mM) - optional",
    "negative": "Vehicle (media only)",
    "technical": "Blank wells (no cells) for background subtraction"
  },
  "success_criteria": {
    "metric": "Calcium transient amplitude (Fluo-4 fluorescence)",
    "threshold": ">20% change vs. vehicle control",
    "statistics": "One-way ANOVA with Dunnett's post-hoc"
  }
}
```

---

# Quick Reference: Hackathon Timeline

| Time | Activity |
|------|----------|
| **Hour 0-2** | Protocol development, reagent prep, Opentrons setup |
| **Hour 2-3** | Run treatment protocol on Opentrons |
| **Hour 3-4** | Transfer to incubator, set up imaging/analysis pipelines |
| **Hour 4-22** | Incubation (do parallel experiments, analyze literature, prep analysis scripts) |
| **Hour 22-23** | Add Fluo-4, 30 min incubation |
| **Hour 23-24** | Plate reader measurement, data analysis, prepare presentation |

---

# Key References

1. **Pocock et al. (2025)** Nature Cardiovasc Research - AMPK/ERR maturation protocol
2. **Song et al. (2024)** Cell Death Dis - Multi-cellular heart organoids for MI modeling
3. **Liao et al. (2024)** J Cell Mol Med - Cardiac resident macrophage biology
4. **Silva et al. (2021)** Cell Stem Cell - Co-emergence of cardiac and gut tissues promotes maturation
5. **Mills et al.** Heart-Dyno platform for functional cardiac organoid screening
